Biology Reference
In-Depth Information
236. Beisel C, Paro R (2011) Silencing chromatin: comparing modes and mechanisms. Nat Rev
Genet 12:123-135
237. Goodchild J (2011) Therapeutic oligonucleotides. Methods Mol Biol 764:1-15
238. Crooke ST (1998) Vitravene-another piece in the mosaic. Antisense Nucleic Acid Drug Dev
8:vii-viii
239. van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout
M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM et al (2007) Local dystrophin
restoration with antisense oligonucleotide PRO051. N Engl J Med 357:2677-2686
240. Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling
T, Janson AA, Platenburg GJ, Sipkens JA et al (2011) Systemic administration of PRO051 in
Duchenne's muscular dystrophy. N Engl J Med 364:1513-1522
241. Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, Dirksen RT, Thornton CA (2009)
Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.
Science 325:336-339
242. Nakamori M, Gourdon G, Thornton CA (2011) Stabilization of expanded (CTG)*(CAG)
repeats by antisense oligonucleotides. Mol Ther 19:2222-2227
243. Stephenson ML, Zamecnik PC (1978) Inhibition of Rous sarcoma viral RNA translation by a
specific oligodeoxyribonucleotide. Proc Natl Acad Sci U S A 75:285-288
244. Elbashir SM, Harborth J, Weber K, Tuschl T (2002) Analysis of gene function in somatic
mammalian cells using small interfering RNAs. Methods 26:199-213
Search WWH ::
Custom Search